Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA)

Organ Preservation in Rectal AdenoCa Using Hypofractionated Pelvic RT(Hypo-OPRA) is a phase 2, interventional study registered as NCT06991465 by Neil Kopek, with a registry enrolment figure of 35 participants, started 2023-08-16 and due to reach its primary completion in 2027-09. Interventions recorded: Radiation Therapy; FOLFOX regimen; Capecitabine. Conditions listed: Colorectal Carcinoma. Primary outcome: Feasibility of Hypo-fractionated Approach in 5 fractions for a dose of 35Gy. Colorectal eligibility wording from the registry: "* Histologically confirmed invasive adenocarcinoma of the rectum". Sites: Canada. No results are recorded here; the registry entry is the source.